TipRanks
Go Ultimate55% OFF

Pulmuone Corporate (017810) Price & Analysis

017810 Stock Chart & Stats

$8,040.00-$80.00(-0.99%)
At close: 4:00 PM EDT
$8,000$8,500$9,000$9,5003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$8,000.00 - $8,610.00
52-Week Range
$8,000.00 - $14,120.00
Previous Close
$8,120.00
Volume
N/A
Average Volume (3M)
13.36K
Market Cap
KRW 296.62B
Enterprise Value
KRW 1.94T
Total Cash (Recent Filing)
KRW 164.54B
Total Debt (Recent Filing)
KRW 1.40T
Price to Earnings (P/E)
10.3
Beta
-0.03
Next Earnings
Nov 18, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
1.27%

Bulls Say, Bears Say

Bulls Say

Steady Revenue Expansion

Sustained revenue expansion indicates continued demand for Pulmuone’s packaged and prepared food portfolio. Durable top-line momentum can support scale, strengthen channel presence, and provide a foundation for earnings growth if the company maintains pricing and cost discipline.

Earnings Recovery

The recovery from the 2022 loss and improvement over 2025 show that earnings power has strengthened rather than remaining structurally depressed. If this progress persists, higher profitability can improve internal funding capacity and support more resilient operations.

Improving Cash Generation

Consistently positive operating cash flow and renewed free cash flow provide evidence that the business is generating cash from operations. Further strengthening could improve funding flexibility, support investment, and gradually reduce dependence on external financing over time.

Bears Say

High Financial Leverage

Very high leverage leaves Pulmuone with less balance-sheet flexibility when earnings weaken or financing costs rise. The small equity base relative to assets amplifies financial risk and may constrain investment, distributions, or strategic responses over the next several quarters.

Limited Debt-Coverage Capacity

Although cash flow is positive, weak conversion of TTM earnings into free cash flow and modest debt coverage limit the company’s ability to deleverage organically. This increases refinancing sensitivity and leaves less cash available for growth or balance-sheet repair.

Thin Profit Margins

Thin net margins and incomplete recovery from 2024 leave earnings vulnerable to cost increases and pricing pressure. Limited margin cushion can make future profit growth less durable, particularly if revenue continues rising without comparable operating leverage.

017810 FAQ

What was Pulmuone Corporate’s price range in the past 12 months?
Pulmuone Corporate lowest stock price was $8000.00 and its highest was $14120.00 in the past 12 months.
What is Pulmuone Corporate’s market cap?
Pulmuone Corporate’s market cap is ₩296.62B.
When is Pulmuone Corporate’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pulmuone Corporate’s earnings last quarter?
Pulmuone Corporate released its earnings results on Aug 14, 2026. The company reported $214.631 earnings per share for the quarter.
Is Pulmuone Corporate overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Pulmuone Corporate pay dividends?
Pulmuone Corporate pays a ― dividend of $102 which represents an annual dividend yield of 1.27%. See more information on Pulmuone Corporate dividends here
What is Pulmuone Corporate’s EPS estimate?
Pulmuone Corporate’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pulmuone Corporate have?
Pulmuone Corporate has 38,120,540 shares outstanding.
What happened to Pulmuone Corporate’s price movement after its last earnings report?
Pulmuone Corporate reported an EPS of $214.631 in its last earnings report. Following the earnings report the stock price went up 6.87%.
Which hedge fund is a major shareholder of Pulmuone Corporate?
Currently, no hedge funds are holding shares in KR:017810
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology